Simranjit Singh
Showing 1–2 of 2 transcripts.
- Milken Institute47 min
Advancing Precision Oncology: Prevention, Early Detection, & Treatment | Middle East & Africa Summit
Alan Tisch, Georges Pascal Haber, Majed Mohammed, Simranjit Singh, Nicole Sirotin
A comprehensive panel discussion detailed the global shift toward precision oncology and AI-driven drug discovery, highlighting how biomarker-specific treatments and metabolic interventions are projecting a transition where cancer becomes a manageable chronic condition by 2050. The event underscored strategic initiatives in the UAE, including the Emirati Genome Project and GLP-1 repurposing, which aim to address regional screening disparities and reduce mortality through early detection and preventive care models. Experts further emphasized the integration of robotic surgery advancements and mRNA technologies alongside robust patient advocacy to bridge the gap between innovative clinical protocols and accessible public health infrastructure.
- Milken Institute46 min
Shifting from Reactive to Proactive Health Care | Asia Summit 2024
Sung Hee Choe, Binayak Dutta, Amit Kakar, Lance Little, Simranjit Singh, Tracey Woon, Simran Singh
Facing a healthcare expenditure projected to surpass defense spending by 2030, Singapore launched the Healthier SG initiative to shift focus from acute treatment to preventive care managed by general practitioners. This strategic pivot addresses critical gaps in chronic disease management and early cancer detection by leveraging government incentives, while innovators like Roche Diagnostics and Novo Holdings introduce self-sampling technologies and AI diagnostics to overcome behavioral barriers and workforce shortages. Despite these advances, stakeholders emphasize that sustained progress requires resolving regulatory friction, aligning financial incentives for prevention, and accelerating patient adoption through targeted behavioral nudges and dynamic insurance models.